Volume 13, Issue 4, Pages (October 2013)

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair Francesco S. Loffredo, Matthew L. Steinhauser,
Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Fate Restriction and Multipotency in Retinal Stem Cells Lázaro Centanin, Burkhard Hoeckendorf, Joachim Wittbrodt Cell Stem Cell Volume 9, Issue 6, Pages.
Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle Isabel Beerman, Jun Seita, Matthew A.
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Scott N. Freeman, Kathryn A. Burke, Menfo A. Imoisili, Timothy R. Coté 
Volume 1, Issue 1, Pages (June 2007)
Human Induced Pluripotent Stem Cells: Now Open to Discovery
Volume 4, Issue 1, Pages (January 2009)
The LUNGe to Model Alveolar Lung Diseases in a Dish
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
A Path to Insulin Independence: “The End of the Beginning”
Volume 9, Issue 2, Pages (August 2011)
Volume 16, Issue 6, Pages (June 2015)
Tamir Rashid, Toshihiro Kobayashi, Hiromitsu Nakauchi  Cell Stem Cell 
Screening for Novel Regulators of Embryonic Stem Cell Identity
Anselme Perrier, Marc Peschanski  Cell Stem Cell 
Public Private Partnerships: A Marriage of Necessity
Volume 21, Issue 6, Pages (December 2017)
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Wing Y. Chang, William L. Stanford  Cell Stem Cell 
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Wenlian Qiao, Peter W. Zandstra  Cell Stem Cell 
Screening for Novel Regulators of Embryonic Stem Cell Identity
Robert Zweigerdt, Ina Gruh, Ulrich Martin  Cell Stem Cell 
Human Induced Pluripotent Stem Cells: Now Open to Discovery
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
MicroRNA Regulation of Stem Cell Fate
Volume 16, Issue 2, Pages (February 2015)
Organoid Center Strategies for Accelerating Clinical Translation
Putting Two Heads Together to Build a Better Brain
MicroRNAs in Tfh Cells: Micromanaging Inflammaging
Not So Lonely at the Top for Cancer Stem Cells
Angela Nakauka-Ddamba, Christopher J. Lengner  Cell Stem Cell 
The Nexus of Tet1 and the Pluripotency Network
Volume 18, Issue 2, Pages (February 2016)
Loukia Yiangou, Alexander D.B. Ross, Kim Jee Goh, Ludovic Vallier 
Pluripotent Stem Cells and Disease Modeling
Order from Chaos: Single Cell Reprogramming in Two Phases
The Promise and Perils of Stem Cell Therapeutics
Volume 21, Issue 1, Pages (July 2017)
Powering Reprogramming with Vitamin C
Volume 16, Issue 1, Pages (January 2015)
Regulating Autologous Adult Stem Cells: The FDA Steps Up
Direct Conversion Provides Old Neurons from Aged Donor’s Skin
Policy Uncertainty and the Conduct of Stem Cell Research
Selfish Stem Cells Compete with Each Other
The Side Story of Stem-like Glioma Cells
Volume 22, Issue 4, Pages (April 2018)
Regulating Autologous Adult Stem Cells: The FDA Steps Up
Chapter 29 - Stem Cells and Generation of New Cells in the
Volume 163, Issue 2, (October 2015)
Using Notches to Track Mammary Epithelial Cell Homeostasis
Mesp1 at the Heart of Mesoderm Lineage Specification
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Presentation transcript:

Volume 13, Issue 4, Pages 389-391 (October 2013) iPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening  Mahendra Rao  Cell Stem Cell  Volume 13, Issue 4, Pages 389-391 (October 2013) DOI: 10.1016/j.stem.2013.09.005 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 A Possible Crowdsourcing Model for iPSC Access The schematic represents an outline for a possible crowdsourcing strategy and summarizes the relative advantages of the model. A key component of the model is that it would be important to include a fee to cover ongoing costs and redeposition of new lines for the strategy to be self-sustaining. Cell Stem Cell 2013 13, 389-391DOI: (10.1016/j.stem.2013.09.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 The NIHCRM Execution Strategy The NIH can play a key role at various stages of generating an implementing the iPSC crowdsourcing strategy, including (1) jumpstarting the strategy by providing initial funding and initial deposit of lines, (2) enforcing regulations, and (3) acting as an honest broker between various stakeholders. Cell Stem Cell 2013 13, 389-391DOI: (10.1016/j.stem.2013.09.005) Copyright © 2013 Elsevier Inc. Terms and Conditions